Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin pathway for management of patients with abnormal PSA
2004-000805-23Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of levofloxacin in prostatitis and prostate-specific antigen abnormality (2 arms), sponsored by GSK. Started Mar 2006; status: completed.
02
Drugs
levofloxacin
03
Conditions
prostatitisprostate-specific antigen abnormality
Beyond the preview
Go deeper on 2004-000805-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000805-23.